US Anticoagulation Therapy Market is Projected to Grow at a CAGR of 7.87% During the Forecast period (2017-2025)

US Anticoagulation Therapy Market

According to Goldstein Research, progress of the anticoagulation drugs market in the US is mainly driven by the growing frequency of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and cumulative demand for novel oral anticoagulants (NOACs). Further, rising outpatient anticoagulation therapy, an increasing number of pipeline products under clinical trials and rising heparin trade are spurring the growth of anticoagulation therapy market.

US Anticoagulation Therapy Market Outlook also includes technological innovations, execution strategy and investment strategies adopted by major market players and regional government in order to expand their business across the globe. However, the high cost of developing drugs and the risk of malfunctions like increased bleeding is the main issue with newer agents are expected to impact the target market negatively.

Download Exclusive Sample Report:

Market Segmentation

United States anticoagulation therapy market report is segmented as follows:

By Product Type

  • Drugs
  1. Novel Oral Anticoagulants (NOACs)
  2. Warfarin (VKA)
  3. Other Drugs
  • PT/INR Testing Devices
  1. In-Office Testing Devices
  2. Analyzers
  3. Agents and Kits
  4. Home Testing Devices
  • Service
  1. Testing Services
  2. Consulting Services

By Clinic

  • Hospital Associated Clinic
  • Independent Clinics
  • Pharmacy-based Clinics

Browse Full Report:

US Anticoagulation Therapy Market Analysis” contains the detailed overview of the US Anticoagulation Therapy market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by product type and by clinics.

Additionally, for the detailed analysis, US Anticoagulation Therapy Market Report includes the industry growth drivers, risk analysis, market attractiveness, market challenges, Porter’s five force model, BPS (Base Point Scale) analysis and SWOT analysis.

This market report also comprises the competitive position of some of the major industry players profiling such as:-

  • C. H. Boehringer Sohn
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Pfizer, Daiichi Sankyo

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the US anticoagulation therapy market trends along with the market forecast that will help industry consultants, technology providers, existing players looking for growth opportunities, new market entrants exploring opportunities and other stakeholders to line up their market centred strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts.

Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare industry analysis reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:

Steve Blade

(Global Sales Head)

USA: + 1-646-568-7747

Canada: 1-437-886-1181

UK: +44-203-318-6627

[email protected]

Browse Similar Report: Plasma Protein Therapeutics Market Report

General Health
No Comment

Leave a Reply